Literature DB >> 15548831

Whole blood and leukocyte RNA isolation for gene expression analyses.

Robert J Feezor1, Henry V Baker, Michael Mindrinos, Doug Hayden, Cynthia L Tannahill, Bernard H Brownstein, Adrian Fay, Sandra MacMillan, Jason Laramie, Wenzhong Xiao, Lyle L Moldawer, J Perren Cobb, Krzysztof Laudanski, Carol L Miller-Graziano, Ronald V Maier, David Schoenfeld, Ronald W Davis, Ronald G Tompkins.   

Abstract

The analysis of gene expression data in clinical medicine has been plagued by the lack of a critical evaluation of accepted methodologies for the collection, processing, and labeling of RNA. In the present report, the reliability of two commonly used techniques to isolate RNA from whole blood or its leukocyte compartment was compared by examining their reproducibility, variance, and signal-to-noise ratios. Whole blood was obtained from healthy subjects and was either untreated or stimulated ex vivo with Staphylococcus enterotoxin B (SEB). Blood samples were also obtained from trauma patients but were not stimulated with SEB ex vivo. Total RNA was isolated from whole blood with the PAXgene proprietary blood collection system or from isolated leukocytes. Biotin-labeled cRNA was hybridized to Affymetrix GeneChips. The Pearson correlation coefficient for gene expression measurements in replicates from healthy subjects with both techniques was excellent, exceeding 0.985. Unsupervised analyses, including hierarchical cluster analysis, however, revealed that the RNA isolation method resulted in greater differences in gene expression than stimulation with SEB or among different trauma patients. The intraclass correlation, a measure of signal-to-noise ratio, of the difference between SEB-stimulated and unstimulated blood from healthy subjects was significantly higher in leukocyte-derived samples than in whole blood: 0.75 vs. 0.46 (P = 0.002). At the P < 0.001 level of significance, twice as many probe sets discriminated between SEB-stimulated and unstimulated blood with leukocyte isolation than with PAXgene. The findings suggest that the method of RNA isolation from whole blood is a critical variable in the design of clinical studies using microarray analyses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548831     DOI: 10.1152/physiolgenomics.00020.2004

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  92 in total

Review 1.  Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells.

Authors:  M Handfield; H V Baker; R J Lamont
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

2.  Isolation of microarray-grade total RNA, microRNA, and DNA from a single PAXgene blood RNA tube.

Authors:  Mogens Kruhøffer; Lars Dyrskjøt; Thorsten Voss; Raija L P Lindberg; Ralf Wyrich; Thomas Thykjaer; Torben F Orntoft
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

3.  MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples.

Authors:  David A Liebner; Kun Huang; Jeffrey D Parvin
Journal:  Bioinformatics       Date:  2013-10-01       Impact factor: 6.937

4.  Genotype combinations of two IL4 polymorphisms influencing IL-4 plasma levels are associated with different risks of severe malaria in the Malian population.

Authors:  Sandrine Cabantous; Stéphane Ranque; Belco Poudiougou; Abdoulaye Traore; Sofiane Berbache; Joana Vitte; Pierre Bongrand; Ogobara Doumbo; Alain J Dessein; Laurent Abel; Sandrine Marquet
Journal:  Immunogenetics       Date:  2015-05-03       Impact factor: 2.846

5.  Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.

Authors:  Michael G Barnes; Alexei A Grom; Susan D Thompson; Thomas A Griffin; Paul Pavlidis; Lukasz Itert; Ndate Fall; Dawn Paxson Sowders; Claas H Hinze; Bruce J Aronow; Lorie K Luyrink; Shweta Srivastava; Norman T Ilowite; Beth S Gottlieb; Judyann C Olson; David D Sherry; David N Glass; Robert A Colbert
Journal:  Arthritis Rheum       Date:  2009-07

6.  Microfluidic leukocyte isolation for gene expression analysis in critically ill hospitalized patients.

Authors:  Aman Russom; Palaniappan Sethu; Daniel Irimia; Michael N Mindrinos; Steve E Calvano; Iris Garcia; Celeste Finnerty; Cynthia Tannahill; Amer Abouhamze; Julie Wilhelmy; M Cecilia López; Henry V Baker; David N Herndon; Stephen F Lowry; Ronald V Maier; Ronald W Davis; Lyle L Moldawer; Ronald G Tompkins; Mehmet Toner
Journal:  Clin Chem       Date:  2008-03-28       Impact factor: 8.327

7.  RNA-stabilized whole blood samples but not peripheral blood mononuclear cells can be stored for prolonged time periods prior to transcriptome analysis.

Authors:  Svenja Debey-Pascher; Andrea Hofmann; Fatima Kreusch; Gerold Schuler; Beatrice Schuler-Thurner; Joachim L Schultze; Andrea Staratschek-Jox
Journal:  J Mol Diagn       Date:  2011-07       Impact factor: 5.568

8.  Bead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approaches.

Authors:  Andrea Gaarz; Svenja Debey-Pascher; Sabine Classen; Daniela Eggle; Birgit Gathof; Jing Chen; Jian-Bing Fan; Thorsten Voss; Joachim L Schultze; Andrea Staratschek-Jox
Journal:  J Mol Diagn       Date:  2010-03-12       Impact factor: 5.568

9.  Traumatic injury, early gene expression, and gram-negative bacteremia.

Authors:  Callie M Thompson; Chin H Park; Ronald V Maier; Grant E O'Keefe
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

10.  Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients.

Authors:  Alex G Cuenca; Lori F Gentile; M Cecilia Lopez; Ricardo Ungaro; Huazhi Liu; Wenzhong Xiao; Junhee Seok; Michael N Mindrinos; Darwin Ang; Tezcan Ozrazgat Baslanti; Azra Bihorac; Philip A Efron; Joseph Cuschieri; H Shaw Warren; Ronald G Tompkins; Ronald V Maier; Henry V Baker; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.